- Home
- ICUI
ICUI
ICU Medical Inc.
as 07-26-2024 4:00pm EST
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | SAN CLEMENTE |
| Market Cap: | 3.1B | IPO Year: | 1992 |
| Target Price: | $127.00 | AVG Volume (30 days): | 403.6K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.45 | EPS Growth: | N/A |
| 52 Week Low/High: | $78.28 - $179.01 | Next Earning Date: | 08-07-2024 |
| Revenue: | $2,257,132,000 | Revenue Growth: | -2.10% |
| Revenue Growth (this year): | 2.78% | Revenue Growth (next year): | 3.88% |
Stock Insider Trading Activity of ICU Medical Inc. (ICUI)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Voigtlander Christian B. | ICUI | Chief Operating Officer | May 30 '24 | Sell | $103.85 | 10,507 | $1,091,156.15 | 2,032 | SEC Form 4 |
| Voigtlander Christian B. | ICUI | Chief Operating Officer | May 30 '24 | Sell | $104.49 | 2,032 | $212,328.35 | 0 | SEC Form 4 |
| FINNEY ELISHA W | ICUI | Director | May 16 '24 | Sell | $104.95 | 300 | $31,484.25 | 2,129 | SEC Form 4 |
| Sousa Ben | ICUI | Chief Information Officer | May 10 '24 | Sell | $105.55 | 2,000 | $211,090.00 | 1,319 | SEC Form 4 |
| Woolson Daniel | ICUI | VP, GM-Infusion Capital | Mar 15 '24 | Sell | $98.27 | 791 | $77,732.76 | 13,980 | SEC Form 4 |
| LOPEZ GEORGE A | ICUI | Director | Mar 14 '24 | Sell | $101.87 | 7,978 | $812,741.20 | 877,343 | SEC Form 4 |
| LOPEZ GEORGE A | ICUI | Director | Mar 12 '24 | Sell | $101.51 | 1,522 | $154,496.70 | 885,321 | SEC Form 4 |
| LOPEZ GEORGE A | ICUI | Director | Mar 11 '24 | Sell | $104.22 | 1,890 | $196,968.05 | 317,753 | SEC Form 4 |
| LOPEZ GEORGE A | ICUI | Director | Mar 11 '24 | Sell | $101.51 | 1,522 | $154,496.70 | 316,231 | SEC Form 4 |
| Sanzone Virginia Ruth | ICUI | VP, General Counsel | Mar 7 '24 | Sell | $104.57 | 3,300 | $345,088.26 | 4,771 | SEC Form 4 |
| LOPEZ GEORGE A | ICUI | Director | Mar 4 '24 | Sell | $106.79 | 7,051 | $752,992.51 | 353,969 | SEC Form 4 |
| LOPEZ GEORGE A | ICUI | Director | Mar 4 '24 | Sell | $105.77 | 18,954 | $2,004,707.72 | 335,015 | SEC Form 4 |
| LOPEZ GEORGE A | ICUI | Director | Mar 4 '24 | Sell | $105.94 | 15,372 | $1,628,454.34 | 319,643 | SEC Form 4 |
| Voigtlander Christian B. | ICUI | Chief Operating Officer | Mar 4 '24 | Sell | $106.77 | 6,887 | $735,313.97 | 6,716 | SEC Form 4 |
| Voigtlander Christian B. | ICUI | Chief Operating Officer | Mar 4 '24 | Sell | $107.60 | 6,497 | $699,059.66 | 219 | SEC Form 4 |
| Voigtlander Christian B. | ICUI | Chief Operating Officer | Mar 4 '24 | Sell | $108.30 | 219 | $23,716.82 | 0 | SEC Form 4 |
| Smiths Group International Holdings Ltd | ICUI | Feb 29 '24 | Sell | $106.08 | 830,000 | $88,042,250.00 | 1,670,000 | SEC Form 4 | |
| SMITHS GROUP PLC | ICUI | Feb 29 '24 | Sell | $106.08 | 830,000 | $88,042,250.00 | 1,670,000 | SEC Form 4 | |
| Woolson Daniel | ICUI | VP, GM-Infusion Capital | Dec 1 '23 | Sell | $88.03 | 1,729 | $152,196.26 | 9,877 | SEC Form 4 |
Latest ICU Medical Inc. News
ICUI Breaking Stock News: Dive into ICUI Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Strength Seen in Brainsway (BWAY): Can Its 9.3% Jump Turn into More Strength?
GlobeNewswire
2 days ago
ICU Medical Announces Time of Second Quarter 2024 Earnings Conference Call
Argus Research
3 days ago
ICUI: Lowering target price to $101.00
MedTech Dive
4 days ago
ICU Medical to close Minnesota facility, cut 83 jobs
Argus Research
10 days ago
ICUI: Raising target price to $120.00
Argus Research
17 days ago
ICUI: Raising target price to $96.00
Simply Wall St.
a month ago
ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price
MT Newswires
a month ago
Needham Initiates ICU Medical at Hold
Compare ICUI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ICUI ICU Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.